[Experiences in the use of Essaven capsules in the treatment of venous leg diseases. Results of a double-blind study].
The efficacy of Essaven-capsules in venous circulatory disorders of the leg was assessed under the conditions of everyday general practice in a double blind trial including 34 out-patients. During the 4 week-treatment Essaven proved to be significantly superior to a placebo of identical appearance as regards the parameter pain in the legs, skin lesions, circumference of the ankle, and diuretic performance. The dosage was 3 X 2 capsules per day.
D000328:Adult; D002599:Chalcone / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004231:Diuresis / Q000187:drug effects; D004311:Double-Blind Method; D004338:Drug Combinations; D004341:Drug Evaluation; D004487:Edema / Q000188:drug therapy; D004928:Escin / Q000627:therapeutic use*; D005419:Flavonoids / Q000627:therapeutic use*; D006569:Hesperidin / Q000627:therapeutic use*; D006801:Humans; D010146:Pain / Q000188:drug therapy; D011427:Propiophenones / Q000627:therapeutic use*; D012503:Saponins / Q000627:therapeutic use*; D012877:Skin Manifestations / Q000188:drug therapy; D013923:Thromboembolism / Q000188:drug therapy*
D004338:Drug Combinations; D005419:Flavonoids; D011427:Propiophenones; D012503:Saponins; D002599:Chalcone; D004928:Escin; D006569:Hesperidin
Erfahrungen in der Behandlung venöser Beinleiden mit Essaven-Kapseln.